Norflex and Paba poisoning - a phase IV clinical study of FDA data
We study 1,758 people who take Norflex or have Paba poisoning. No report of Paba poisoning is found in people who take Norflex.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Norflex?
Norflex has active ingredients of orphenadrine citrate. It is often used in muscle spasms. eHealthMe is studying from 1,757 Norflex users for its effectiveness, alternative drugs and more.
What is Paba Poisoning?
Paba poisoning: no further information found.
Do you take Norflex and have Paba poisoning?Check whether Paba poisoning is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Norflex:
- Norflex (1,757 reports)
Paba poisoning treatments and more:
- Paba poisoning (1 reports)
COVID vaccines that are related to Paba poisoning:
- Paba poisoning in Moderna COVID Vaccine
- Paba poisoning in Pfizer BioNTech Covid Vaccine
- Paba poisoning in Johnson and Johnson Covid Vaccine
How severe was Paba poisoning and when was it recovered:
Expand to all the drugs that have ingredients of orphenadrine citrate:
All the drugs that are associated with Paba poisoning:
All the conditions that are associated with Paba poisoning:
How the study uses the data?
The study uses data from the FDA. It is based on orphenadrine citrate (the active ingredients of Norflex) and Norflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Trilipix and Peritonitis - 2 seconds ago
- Letrozole and Ocular Hyperaemia - 7 seconds ago
- Helicobacter Infection and Anaplastic Large Cell Lymphoma T- And Null-Cell Types Stage Ii - 8 seconds ago
- Policosanol and Ubidecarenone drug interaction - 9 seconds ago
- Viread and Depo-Testosterone drug interaction - 14 seconds ago